awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35336802-26A1FD82-1E4B-49D2-9D9A-84F0C5650F1C
Q35336802-26A1FD82-1E4B-49D2-9D9A-84F0C5650F1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35336802-26A1FD82-1E4B-49D2-9D9A-84F0C5650F1C
The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug
P2860
Q35336802-26A1FD82-1E4B-49D2-9D9A-84F0C5650F1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35336802-26A1FD82-1E4B-49D2-9D9A-84F0C5650F1C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
88026677801d005917b61e64d49eb905a5be2e79
P2860
Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease